Non-invasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy is an optimal selection criteria for bladder-sparing strategy in muscle-invasive bladder cancer

Bibliographic Details
Main Authors:	T. Onishi, S. Sekito, T. Shibahara, T. Terabe, T. Yabana
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320341379

Repeated transurethral resection in non-muscle invasive bladder cancer
by: Ivan VLADANOV, et al.
Published: (2021-03-01)

Invasive bladder cancer in the eighties: transurethral resection or cystectomy?
by: Oscar Rodriguez Faba, et al.
Published: (2011-02-01)

Predicting recurrence of non-muscle-invasive bladder cancer after transurethral resection
by: Haris Ðug, et al.
Published: (2016-02-01)

Transurethral „en bloc“ resection technique in non-muscle invasive bladder cancer
by: Ivan VLADANOV, et al.
Published: (2020-06-01)

Current and innovative approaches in the treatment of non-muscle invasive bladder cancer: the role of transurethral resection of bladder tumor and organoids
by: Taskovska Milena, et al.
Published: (2020-05-01)

Case report: Bladder preserving after maximal transurethral resection of the bladder tumor combined with chemotherapy and immunotherapy in recurrent muscle-invasive bladder cancer patients: A report of two cases
by: Jiaquan Mao, et al.
Published: (2022-08-01)

Comparison of holmium laser, bipolar and conventional monopolar transurethral resection of bladder tumour in primary non-muscle invasive bladder cancer
by: Salah Elmekawy, et al.
Published: (2023-05-01)

Analysis of risk factors of recurrence in non-muscle invasive bladder cancer patients after initial transurethral resection of bladder tumor
by: TANG Duocai, ZHOU Shukui, ZHANG Guiyin, LIU Lei, LIAO Hong
Published: (2023-05-01)

Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancer
by: Tejpal S Gill, et al.
Published: (2014-01-01)

Hexaminolevulinate blue light cystoscopy (Hal) assisted transurethral resection of the bladder tumour vs white light transurethral resection of the bladder tumour in non-muscle invasive bladder cancer (NMIBC) : a retrospective analysis.
by: Marco Capece, et al.
Published: (2020-04-01)

Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer
by: Witjes JA, et al.
Published: (2021-10-01)

Transurethral resection of bladder tumor-based bladder preservation therapy for refractory high risk non-muscle invasive bladder cancer: Current landscape and future directions
by: Xinghui Sun, et al.
Published: (2023-04-01)

Utility of bladder-sparing therapy vs radical cystectomy for muscle-invasive bladder cancer
by: Efstathiou, J, et al.
Published: (2018)

The Effect of Transurethral Resection and BCG Therapy on Cytokine Levels in Non-Muscle Invasive Bladder Cancer
by: Oktay Üçer, et al.
Published: (2022-09-01)

Initial experience with surrounding en bloc transurethral resection of bladder tumor and simultaneous intravesical treating for non-muscle invasive bladder cancer
by: Lichen Teng, et al.
Published: (2022-11-01)

Quality improvement in managing patients with non-muscle-invasive bladder cancer by introducing a surgical checklist for transurethral resection of bladder tumor.
by: Hiroshi Kikuchi, et al.
Published: (2022-01-01)

Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy
by: Zheng Liu, et al.
Published: (2021-11-01)

Extraperitoneal bladder perforation secondary to transurethral resection of bladder tumor
by: Doan Tien Luu, MD, et al.
Published: (2021-04-01)

A Systematic Review and Meta-Analysis Protocol of Chemoablation vs. Transurethral Resection of Bladder Tumor in Patients With Non-Muscle-Invasive Bladder Cancer
by: Xu Shi, et al.
Published: (2021-11-01)

Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer.
by: Bum Sik Tae, et al.
Published: (2017-01-01)

Erectile dysfunction in nonmuscle-invasive bladder cancer patients before and after transurethral resection (TUR) of bladder tumor in China
by: Peng Guo, et al.
Published: (2022-01-01)

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
by: Kari T. Syvänen, et al.
Published: (2014-05-01)

Transurethral resection for botryoid bladder rhabdomyosarcoma
by: Mitsuyuki Nakata, et al.
Published: (2018-01-01)

Transurethral resection syndrome: A rare complication of intraperitoneal bladder perforation during transurethral resection of bladder tumor
by: Ahmed Ibrahimi, et al.
Published: (2021-01-01)

Prediction of intravesical recurrence of non-muscle-invasive bladder cancer by evaluation of intratumoral Foxp3+ T cells in the primary transurethral resection of bladder tumor specimens.
by: Ryosuke Murai, et al.
Published: (2018-01-01)

The Management of Non-Invasive Bladder Tumours with Doxorubicin Intravesical Instillation after Transurethral Resection
by: Musa I Al-Gallab, et al.
Published: (2009-04-01)

Role of second transurethral resection in determining residual tumor in nonmuscle-invasive bladder cancer
by: Pukar Maskey, et al.
Published: (2017-12-01)

Number of transurethral procedures after non-muscle-invasive bladder cancer and survival in causes other than bladder cancer.
by: Lars Holmberg, et al.
Published: (2022-01-01)

An evaluation to define the role of repeat transurethral resection in a treatment algorithm for non-muscle-invasive bladder cancer
by: Atsushi Fujikawa, et al.
Published: (2012-01-01)

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
by: Dalia Elsayed, et al.
Published: (2023-04-01)

The efficacy and safety of thulium laser resection of bladder tumor versus standard transurethral resection in patients with non-muscle-invasive bladder cancer: a systematic review and meta-analysis
by: Yu-Meng Chai, et al.
Published: (2021-04-01)

Comparative analysis between En-bloc resection and transurethral resection of non-muscular invasive bladder tumors
by: Ivan Vladanov, et al.
Published: (2021-06-01)

Intravesical Explosion Resulting in Bladder Rupture During Transurethral Resection of Bladder Tumors
by: Chih-Chiao Lee, et al.
Published: (2014-12-01)

Efficacy and safety of transurethral resection of bladder tumour combined with chemotherapy and immunotherapy in bladder-sparing therapy in patients with T1 high-grade or T2 bladder cancer: a protocol for a randomized controlled trial
by: Xiangwei Yang, et al.
Published: (2023-04-01)

Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit
by: Wojciech Krajewski, et al.
Published: (2020-10-01)

Body composition as a predictor of oncological outcome in patients with non-muscle-invasive bladder cancer receiving intravesical instillation after transurethral resection of bladder tumor
by: Liang-Kang Huang, et al.
Published: (2023-08-01)

Recent advances in transurethral resection of bladder tumors
by: D. I. Babaevskaya, et al.
Published: (2022-04-01)

Recurrent nephroblastoma in the bladder: Successful transurethral resection
by: Siti Hafzan Abd Karim, et al.
Published: (2021-11-01)

Utility of restage transurethral resection of bladder tumor
by: Vignesh Manoharan, et al.
Published: (2018-01-01)

Transurethral needle electrode resection and transurethral holmium laser resection of bladder cancer
by: Yu Zhou, et al.
Published: (2020-07-01)

Non-invasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy is an optimal selection criteria for bladder-sparing strategy in muscle-invasive bladder cancer

Similar Items

Similar Items